Total Payments
$3,329
2024 Payments
$46.09
Companies
29
Transactions
88
Medicare Patients
617
Medicare Billing
$104,457
Payment Breakdown by Category
Food & Beverage$3,329 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,329 | 88 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $777.36 | 10 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $303.37 | 11 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $262.48 | 2 | $0 (2021) |
| Boston Scientific Corporation | $257.18 | 2 | $0 (2019) |
| QOL Medical, LLC | $216.62 | 16 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $204.38 | 6 | $0 (2021) |
| Amniox Medical, Inc. | $125.00 | 1 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $125.00 | 1 | $0 (2017) |
| Ethicon US, LLC | $124.62 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $102.23 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.09 | 2 | DePuy Synthes Sales Inc. ($28.54) |
| 2023 | $141.22 | 8 | QOL Medical, LLC ($62.89) |
| 2022 | $52.67 | 3 | QOL Medical, LLC ($31.35) |
| 2021 | $858.71 | 23 | E.R. Squibb & Sons, L.L.C. ($262.48) |
| 2020 | $204.27 | 6 | Gilead Sciences, Inc. ($160.13) |
| 2019 | $739.88 | 21 | Gilead Sciences, Inc. ($226.85) |
| 2018 | $750.46 | 18 | Gilead Sciences, Inc. ($248.98) |
| 2017 | $535.91 | 7 | BOSTON SCIENTIFIC CORPORATION ($144.64) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Sports Early Intervention | ||||||
| 04/12/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/24/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/15/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $19.22 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/24/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/15/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Gastroenterology | ||||||
| 02/13/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/09/2023 | RedHill Biopharma Inc. | Talicia (Drug), Movantik, Aemcolo | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Antibiotic | ||||||
| 02/01/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/11/2023 | TRICE MEDICAL, INC. | — | Food and Beverage | In-kind items and services | $20.04 | General |
| 07/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/26/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/05/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/03/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Chronic Pain | ||||||
| 11/02/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: KRYSTEXXA | ||||||
| 10/27/2021 | Interventional Pain Technologies Inc. | — | Food and Beverage | Cash or cash equivalent | $75.48 | General |
| 10/20/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 10/07/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Chronic Pain | ||||||
| 09/02/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Chronic Pain | ||||||
| 08/19/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neuroscience | ||||||
| 08/05/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Chronic Pain | ||||||
| 07/29/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $137.49 | General |
| Category: Neuroscience | ||||||
| 07/28/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/28/2021 | Alfasigma USA, Inc. | Zelnorm (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: IBS-C | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 214 | 419 | $221,722 | $26,920 |
| 2022 | 3 | 109 | 178 | $127,971 | $18,455 |
| 2021 | 5 | 153 | 262 | $205,866 | $26,806 |
| 2020 | 7 | 141 | 350 | $204,405 | $32,277 |
Total Patients
617
Total Services
1,209
Medicare Billing
$104,457
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 167 | $136,242 | $17,015 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $36,777 | $4,244 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 39 | $22,343 | $2,800 | 12.5% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 26 | 62 | $11,408 | $1,356 | 11.9% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 26 | 61 | $10,370 | $1,046 | 10.1% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 22 | 38 | $2,926 | $295.64 | 10.1% |
| 97035 | Application of ultrasound, each 15 minutes | Office | 2023 | 14 | 18 | $1,656 | $163.98 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 117 | $79,670 | $11,949 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $35,530 | $4,868 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 27 | $12,771 | $1,637 | 12.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 140 | $95,760 | $15,036 | 15.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $40,755 | $5,327 | 13.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 54 | $25,542 | $3,884 | 15.2% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 12 | 15 | $29,565 | $1,643 | 5.6% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2021 | 11 | 14 | $14,244 | $915.72 | 6.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 261 | $142,333 | $23,101 | 16.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $14,685 | $3,167 | 21.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $8,070 | $1,600 | 19.8% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 11 | 13 | $15,450 | $1,487 | 9.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 19 | $7,943 | $1,172 | 14.8% |
| 64495 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 11 | 13 | $7,932 | $880.58 | 11.1% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 11 | 13 | $7,992 | $869.73 | 10.9% |
About Dr. Daniel Marin, MD
Dr. Daniel Marin, MD is a Pain Medicine healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396920161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Marin, MD has received a total of $3,329 in payments from pharmaceutical and medical device companies, with $46.09 received in 2024. These payments were reported across 88 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,329).
As a Medicare-enrolled provider, Marin has provided services to 617 Medicare beneficiaries, totaling 1,209 services with total Medicare billing of $104,457. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Miami, FL
- Active Since 12/29/2007
- Last Updated 11/28/2023
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1396920161
Products in Payments
- Epclusa (Drug) $696.85
- ZEPOSIA (Drug) $262.48
- XIFAXAN (Drug) $208.17
- BELBUCA (Drug) $204.38
- Sucraid (Drug) $170.17
- GENERAL - BIOPSY (Device) $144.64
- STELARA (Biological) $129.11
- NEOX (Biological) $125.00
- Trulance (Drug) $125.00
- CERTUS 140 MICROWAVE ABLATION SYSTEM (Device) $124.62
- HABIB ENDOHPB (Device) $112.54
- DALVANCE (Drug) $94.09
- Intracept (Device) $78.89
- Prokera (Device) $76.19
- Cimzia (Drug) $74.71
- MOVIPREP (Drug) $53.78
- APRISO (Drug) $53.44
- ORTHOVISC (Device) $52.85
- SUCRAID (Drug) $46.45
- Entyvio (Biological) $41.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Miami
Vivian Hernandez-Popp, M.d,, M.D,
Pain Medicine — Payments: $15,306
Pain Medicine $15,306
Dr. Ruben Schwartz, Do, DO
Pain Medicine — Payments: $13,790
Pain Medicine $13,790
Abel Murillo, Md. Dabpm. Fipp. Mba, MD. DABPM. FIPP. MBA
Pain Medicine — Payments: $9,318
Pain Medicine $9,318
Dr. Maximiliano Velasco, M.d, M.D
Pain Medicine — Payments: $9,058
Pain Medicine $9,058
Dr. Seyed Mostoufi, M.d, M.D
Pain Medicine — Payments: $8,581
Pain Medicine $8,581
Dr. Ronald Gutman, Md, MD
Pain Medicine — Payments: $7,936
Pain Medicine $7,936